On Wednesday, AdaptHealth stock received a positive adjustment to its Relative Strength (RS) Rating, from 64 to 71.
When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.
IBD's unique RS Rating measures market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
History reveals that the best stocks tend to have an 80 or higher RS Rating in the early stages of their moves. See if AdaptHealth stock can continue to show renewed price strength and clear that threshold.
Looking For The Best Stocks To Buy And Watch? Start Here
Is AdaptHealth Stock A Buy?
AdaptHealth stock is trying to complete a cup without handle with a 27.58 entry. See if the stock can clear the breakout price in heavy trade.
The medical home care company reported -45% earnings growth last quarter. Sales gains came in at 16%.
AdaptHealth stock holds the No. 6 rank among its peers in the Medical-Outpatient/Home Care industry group. Addus HomeCare and Encompass Health are also among the group's highest-rated stocks.
YOU MAY ALSO LIKE:
MarketSmith's Tools Can Help The Individual Investor
IBD Live: A New Tool For Daily Stock Market Analysis
Profit From Short-Term Trends With SwingTrader
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks